Racial and ethnic differences in COVID-19 outcomes: a call to action
Digital Health Strategies to Fight COVID-19 Worldwide: Challenges, Recommendations, and a Call for Papers – PMC
08/06/2022COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records
09/06/2022Racial and ethnic differences in COVID-19 outcomes: a call to action
The COVID-19 pandemic has demanded a huge effort to identify the risks associated
with poor outcomes. The focus has been particularly relevant in patients with immune-mediated
inflammatory diseases and those on therapies that suppress the immune system. Small
early observational studies looked worrisome, but as data from larger studies became
available a consistent picture became evident. Demographic risk factors such as age
and comorbidity are really the salient factors, with some risk from underlying disease
and a few specific therapeutic agents, such as rituximab.
Lire l'article complet sur : www.thelancet.com
The COVID-19 pandemic has demanded a huge effort to identify the risks associated
with poor outcomes. The focus has been particularly relevant in patients with immune-mediated
inflammatory diseases and those on therapies that suppress the immune system. Small
early observational studies looked worrisome, but as data from larger studies became
available a consistent picture became evident. Demographic risk factors such as age
and comorbidity are really the salient factors, with some risk from underlying disease
and a few specific therapeutic agents, such as rituximab.
Lire l’article complet sur : www.thelancet.com
